The content on this site is intended for healthcare professionals only
Dr Quenet presents results at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting from the PRODIGE 7 trial.
This was a phase III randomised trial in which patients with stage IV non-metastatic colorectal cancer received surgical treatment with or without heated oxaliplatin chemotherapy.
Dr Quenet describes the median overall survival at 64 months in both groups as equal, the time to disease recurrence as similar and that the addition of chemotherapy doubled the rate of complications.
For more on these results, watch his interview with ecancer, or read news coverage here.
Rectal cancer
KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer
Feasibility and safety of boost at 74 Gy based on interim FDG-PET during thoracic radio-chemotherapy for NSCLC patients
Adjuvant radiotherapy has no benefit following radical prostatectomy
Neoadjuvant cemiplimab shows favourable event-free, disease-free and overall survival rates in patients with resectable CSCC
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
OncoAlert Round Up for September 15-21, 2023
OncoAlert Round Up for August 25th - 31st, 2023
OncoAlert Round Up for August 4th - 10th, 2023
